# Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients

> **NCT04497389** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 47 (actual)

## Conditions studied

- SARS CoV-2

## Interventions

- **BIOLOGICAL:** Human Amniotic Fluid

## Key facts

- **NCT ID:** NCT04497389
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-28
- **Primary completion:** 2022-08-02
- **Final completion:** 2023-02-15
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2023-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04497389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04497389, "Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04497389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*